What is the treatment for a corneal ulcer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Corneal Ulcers

Initiate immediate topical fluoroquinolone antibiotic therapy with a loading dose every 5-15 minutes followed by hourly applications for bacterial keratitis, as this represents the cornerstone of treatment and can achieve high tissue levels to prevent vision-threatening complications. 1

Diagnostic Approach

Obtain corneal scrapings before starting treatment using topical anesthetic and a sterile instrument to collect material from the base or periphery of the infection, with samples inoculated directly onto culture media. 1 A nylon-tipped flocked swab shows similar culture positivity rates to traditional methods. 1 Avoid tetracaine as an anesthetic for scraping as it has antimicrobial effects that interfere with culture results. 1

For deep stromal infections or poor treatment response, corneal biopsy may be indicated. 1

Initial Antibiotic Therapy

Topical antibiotics are the preferred treatment method:

  • Single fluoroquinolone therapy is as effective as combination fortified antibiotics for most cases. 1
  • FDA-approved options include ciprofloxacin 0.3%, ofloxacin 0.3%, and levofloxacin 1.5%. 1
  • Fortified topical antibiotics should be considered for large and/or visually significant infiltrates, especially with hypopyon present. 1
  • Loading dose: every 5-15 minutes, then hourly for central or severe keratitis. 1

Systemic antibiotics are rarely needed but may be considered when infection extends to adjacent tissues (e.g., sclera) or with impending/frank perforation. 2 Gonococcal keratitis requires systemic therapy. 2

Monitoring Protocol

  • Follow daily initially until clinical improvement is confirmed, especially for severe cases (deep stromal involvement or infiltrates >2mm). 2
  • If cultures are negative with poor clinical response, stop antibiotics for 12-24 hours then reculture. 1

Adjunctive Therapies

Cycloplegic agents should be used to decrease synechiae formation and reduce pain from anterior segment inflammation. 1

Corticosteroid Use - Critical Timing

Add topical corticosteroids only after at least 2-3 days of progressive improvement with antibiotics, typically after pathogen identification and ruling out fungal infection. 2, 1 The American Academy of Ophthalmology's 2024 guidelines emphasize this conservative approach. 2

Key corticosteroid considerations:

  • Use the minimum amount required to control inflammation. 2
  • Avoid in Nocardia keratitis - results in poor visual outcomes. 2
  • Avoid in fungal keratitis until infection is controlled. 2
  • Potential benefit exists for Pseudomonas keratitis and severe cases (ulcers covering central 4-mm pupil or vision of counting fingers or worse). 2
  • Earlier addition (within 2-3 days vs. after 4+ days) resulted in 1-line better visual acuity at 3 months in non-Nocardia cases. 2
  • Monitor intraocular pressure and watch for cataract formation with long-term use. 2

If patient is already on topical corticosteroids at presentation, reduce or eliminate the regimen until infection is controlled. 2, 1

Surgical Management for Impending Perforation

For corneal thinning or small perforations:

  • Cyanoacrylate tissue adhesive is the primary intervention for areas of marked thinning or early descemetocele. 2
  • The base must be dry for adhesive to adhere properly. 2
  • Works best when the area is small and at the bottom of a crater, not with ballooning descemetocele. 2
  • May remain in place for 6+ weeks if applied to a clean, compact base. 2
  • Do not use fibrin glue - it biodegrades too rapidly before healing occurs. 2
  • Apply bandage contact lenses to prevent glue dislocation and provide comfort. 2

For leaking descemetoceles, inject an air bubble into the anterior chamber to temporarily halt leakage while applying glue. 2

Special Populations and Situations

Contact lens-related keratitis:

  • Do not patch the eye or use therapeutic contact lenses for contact lens wearers with corneal abrasions due to increased risk of secondary bacterial keratitis. 1
  • Educate about risks: extended wear has 20 per 10,000 incidence vs. 1-2 per 10,000 for daily wear. 2
  • Consider switching to daily disposable lenses after resolution. 2

Recurrent bacterial keratitis (more likely S. aureus) may require decolonization of nasopharynx, oropharynx, and ocular surface. 2

Moraxella keratitis requires prolonged treatment duration (mean 41.9 days) despite susceptibility to fluoroquinolones and aminoglycosides. 2

Critical Pitfalls to Avoid

  • Never delay culture and sensitivity testing - this leads to ineffective treatment. 1
  • Never use corticosteroids in Nocardia or fungal keratitis - outcomes are poor. 2, 1
  • Never continue ineffective therapy beyond 7-10 days without clinical re-evaluation and additional laboratory studies. 3
  • Chronic topical immunotherapy increases risk of infectious crystalline keratopathy. 2, 1
  • Overuse of prophylactic antibiotics promotes resistant organisms. 1

When to Refer/Hospitalize

Immediate ophthalmology referral is required for all corneal ulcers. 4 Hospitalization may be necessary if keratitis is severe, vision-threatening, compliance is unlikely, pain is severe, or patient cannot self-administer drops due to age, mental, or physical disability. 2

References

Guideline

Management of Corneal Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Corneal ulcers in general practice.

Australian journal of general practice, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.